Genes upregulated in cluster 2 are involved in interferon γ signaling, TNF α, and allograft rejection, suggesting an immunomodulatory role for iloprost, as has been shown in mouse models of pulmonary hypertension and lung carcinoma (28–30). The gene discussed is TNF; the disease is pulmonary arterial hypertension.